Supernus Pharmaceuticals Inc (SUPN)
36.75
+1.99
(+5.72%)
USD |
NASDAQ |
Nov 05, 09:38
Supernus Pharmaceuticals Shareholders Equity (Quarterly): 957.45M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 957.45M |
| March 31, 2024 | 929.17M |
| December 31, 2023 | 921.52M |
| September 30, 2023 | 912.19M |
| June 30, 2023 | 919.91M |
| March 31, 2023 | 912.15M |
| December 31, 2022 | 886.20M |
| September 30, 2022 | 852.80M |
| June 30, 2022 | 841.43M |
| March 31, 2022 | 828.45M |
| December 31, 2021 | 815.85M |
| September 30, 2021 | 810.47M |
| June 30, 2021 | 785.58M |
| March 31, 2021 | 754.44M |
| December 31, 2020 | 744.86M |
| September 30, 2020 | 708.88M |
| June 30, 2020 | 665.97M |
| March 31, 2020 | 613.38M |
| December 31, 2019 | 595.43M |
| September 30, 2019 | 557.26M |
| June 30, 2019 | 522.90M |
| March 31, 2019 | 480.02M |
| December 31, 2018 | 453.02M |
| September 30, 2018 | 421.94M |
| June 30, 2018 | 390.49M |
| Date | Value |
|---|---|
| March 31, 2018 | 351.87M |
| December 31, 2017 | 267.48M |
| September 30, 2017 | 251.66M |
| June 30, 2017 | 229.40M |
| March 31, 2017 | 206.06M |
| December 31, 2016 | 191.76M |
| September 30, 2016 | 173.37M |
| June 30, 2016 | 141.02M |
| March 31, 2016 | 128.14M |
| December 31, 2015 | 88.01M |
| September 30, 2015 | 109.44M |
| June 30, 2015 | 102.36M |
| March 31, 2015 | 94.58M |
| December 31, 2014 | 40.70M |
| September 30, 2014 | 66.12M |
| June 30, 2014 | 33.37M |
| March 31, 2014 | 29.01M |
| December 31, 2013 | 33.46M |
| September 30, 2013 | 12.45M |
| June 30, 2013 | 35.89M |
| March 31, 2013 | 41.27M |
| December 31, 2012 | 57.57M |
| September 30, 2012 | 24.63M |
| June 30, 2012 | 37.98M |
| March 31, 2012 | 0.274M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
595.43M
Minimum
Dec 2019
957.45M
Maximum
Jun 2024
813.48M
Average
828.45M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 516.70M |
| Regeneron Pharmaceuticals Inc | 29.33B |
| United Therapeutics Corp | 6.101B |
| Ligand Pharmaceuticals Inc | 775.20M |
| Myomo Inc | 9.678M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.316B |
| Total Liabilities (Quarterly) | 358.38M |
| Current Ratio | 1.915 |
| Net Debt Paydown Yield | 6.53% |